journal article·2022-07-13Open access

Cryptococcus: History, Epidemiology and Immune Evasion

Israel Diniz-Lima, Leonardo Marques da Fonseca, Elias Barbosa da Silva-Junior, Joyce Cristina Guimarães-de-Oliveira, Leonardo Freire-de-Lima, Danielle Oliveira Nascimento, Alexandre Morrot, Jose Osvaldo Previato, Lucia Mendonça-Previato, Debora Decote-Ricardo, Celio Geraldo Freire-de-Lima

Applied Sciences· Volume 12· Issue 14

Abstract

Cryptococcosis is a disease caused by the pathogenic fungi Cryptococcus neoformans and Cryptococcus gattii, both environmental fungi that cause severe pneumonia and may even lead to cryptococcal meningoencephalitis. Although C. neoformans affects more fragile individuals, such as immunocompromised hosts through opportunistic infections, C. gattii causes a serious indiscriminate primary infection in immunocompetent individuals. Typically seen in tropical and subtropical environments, C. gattii has increased its endemic area over recent years, largely due to climatic factors that favor contagion in warmer climates. It is important to point out that not only C. gattii, but the Cryptococcus species complex produces a polysaccharidic capsule with immunomodulatory properties, enabling the pathogenic species of Cryptococccus to subvert the host immune response during the establishment of cryptococcosis, facilitating its dissemination in the infected organism. C. gattii causes a more severe and difficult-to-treat infection, with few antifungals eliciting an effective response during chronic treatment. Much of the immunopathology of this cryptococcosis is still poorly understood, with most studies focusing on cryptococcosis caused by the species C. neoformans. C. gattii became more important in the epidemiological scenario with the outbreaks in the Pacific Northwest of the United States, which resulted in phylogenetic studies of the virulent variant responsible for the severe infection in the region. Since then, the study of cryptococcosis caused by C. gattii has helped researchers understand the immunopathological aspects of different variants of this pathogen.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Fungal Infections and Studies · Nail Diseases and Treatments · Antifungal resistance and susceptibility

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21944-970, Brazil

Instituto de Veterinária, Universidade Federal Rural do Rio de Janeiro, Seropédica 23890-000, Brazil

Faculdade de Medicina, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-900, Brazil

Instituto Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21045-900, Brazil

References (100+)

Show source-provided references
2. Projecting global occurrence of Cryptococcus gattii10.3201/eid1601.090369 ↗
3. Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis10.1101/cshperspect.a019760 ↗
4. Chau, T.T., Mai, N.H., Phu, N.H., Nghia, H.D., Chuong, L.V., Sinh, D.X., Duong, V.A., Diep, P.T., Campbell, J.I., and Baker, S. (2010). A prospective descriptive study of cryptococcal meningitis in HIV uninfected patients in Vietnam—High prevalence of Cryptococcus neoformans var grubii in the absence of underlying disease. BMC Infect. Dis., 10.10.1186/1471-2334-10-199 ↗
5. Occurrence of Cryptococcus spp. in excreta of pigeons and pet birds10.1046/j.1439-0507.2000.00534.x ↗
6. Springer, D.J., Billmyre, R.B., Filler, E.E., Voelz, K., Pursall, R., Mieczkowski, P.A., Larsen, R.A., Dietrich, F.S., May, R.C., and Filler, S.G. (2014). Cryptococcus gattii VGIII isolates causing infections in HIV/AIDS patients in Southern California: Identification of the local environmental source as arboreal. PLoS Pathog., 10.10.1371/journal.ppat.1004285 ↗
7. The role of Cryptococcus laurentii and mycorrhizal fungi in the nutritional physiology of Lupinus angustifolius L. hosting N2-fixing nodules10.1007/s11104-016-2973-3 ↗
8. The Disease Ecology, Epidemiology, Clinical Manifestations, and Management of Emerging Cryptococcus gattii Complex Infections10.1016/j.wem.2019.10.004 ↗
9. Ferreira-Paim, K., Ferreira, T.B., Andrade-Silva, L., Mora, D.J., Springer, D.J., Heitman, J., Fonseca, F.M., Matos, D., Melhem, M.S., and Silva-Vergara, M.L. (2014). Phylogenetic analysis of phenotypically characterized Cryptococcus laurentii isolates reveals high frequency of cryptic species. PLoS ONE, 9.10.1371/journal.pone.0108633 ↗
10. Cryptococcus laurentii meningitis in a non-HIV patient10.1016/j.idcr.2019.e00612 ↗
11. Clinical significance of nosocomial Cryptococcus laurentii in urine: A case series10.1017/ice.2019.263 ↗
12. Cryptococcus laurentii fungemia in a low birth weight preterm neonate: India10.1016/j.jiph.2018.04.012 ↗
13. Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans10.1128/CMR.8.4.515 ↗
14. Ascospore formation in the yeast Saccharomyces cerevisiae10.1128/MMBR.69.4.565-584.2005 ↗
15. A history of research on yeasts 14: Medical yeasts part 2, Cryptococcus neoformans10.1002/yea.1786 ↗
16. The antigenic composition of Cryptococcus neoformans. V. A survey of cross-reactions among strains of Cryptococcus and other antigens10.1128/jb.66.3.287-293.1953 ↗
17. The biology of the Cryptococcus neoformans species complex10.1146/annurev.micro.60.080805.142102 ↗
18. Cryptococcus neoformans var
19. Multilocus sequence typing reveals three genetic subpopulations of Cryptococcus neoformans var
20. Molecular typing of global isolates of Cryptococcus neoformans var. neoformans by polymerase chain reaction fingerprinting and randomly amplified polymorphic DNA-a pilot study to standardize techniques on which to base a detailed epidemiological survey10.1002/(SICI)1522-2683(19990101)20:8<1790::AID-ELPS1790>3.0.CO;2-2 ↗
21. Global burden of disease of HIV-associated cryptococcal meningitis: An updated analysis10.1016/S1473-3099(17)30243-8 ↗
22. Pitfalls in Serological Diagnosis of Cryptococcus gattii Infections10.1093/mmy/myv061 ↗
23. Recognition and diagnosis of Cryptococcus gattii infections in the United States10.3201/eid1806.111228 ↗
24. Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C)10.1128/jcm.15.3.535-537.1982 ↗
25. Canavanine resistance in Cryptococcus neoformans10.1128/AAC.29.3.468 ↗
26. Identification of Cryptococcus gattii by use of L-canavanine glycine bromothymol blue medium and DNA sequencing10.1128/JCM.01072-09 ↗
27. Cryptococcus gattii infections10.1128/CMR.00126-13 ↗
28. Genome variation in Cryptococcus gattii, an emerging pathogen of immunocompetent hosts10.1128/mBio.00342-10 ↗
29. Cryptococcus gattii, no longer an accidental pathogen?10.1007/s12281-012-0111-0 ↗
30. Characterization of clinical isolates of the Cryptococcus neoformans-Cryptococcus gattii species complex from the Amazonas State in Brazil10.1016/j.riam.2011.05.003 ↗
31. Cryptococcus gattii VGII isolated from native forest and river in Northern Brazil10.1007/s42770-019-00066-6 ↗
32. Comparative antifungal susceptibility analyses of Cryptococcus neoformans VNI and Cryptococcus gattii VGII from the Brazilian Amazon Region by the Etest, Vitek 2, and the Clinical and Laboratory Standards Institute broth microdilution methods10.1093/mmy/myy150 ↗
33. Genotypes of Cryptococcus neoformans and Cryptococcus gattii as agents of endemic cryptococcosis in Teresina, Piauí (northeastern Brazil)10.1590/S0074-02762011000600012 ↗
34. Genetic Diversity of the Cryptococcus gattii Species Complex in Mato Grosso State, Brazil10.1007/s11046-018-0313-2 ↗
35. High prevalence of Cryptococcus neoformans var gattii in tropical and subtropical regions
36. Molecular typing, in vitro susceptibility and virulence of Cryptococcus neoformans/Cryptococcus gattii species complex clinical isolates from south-eastern Brazil10.1111/myc.13174 ↗
37. Cryptococcosis by Cryptococcus neoformans/Cryptococcus gattii Species Complexes in non-HIV-Infected Patients in Southeastern Brazil10.1590/0037-8682-0169-2021 ↗
38. Cryptococcosis in domestic animals in Western Australia: A retrospective study from 1995-200610.1080/13693780802512519 ↗
39. Cryptococcus gattii in wildlife of Vancouver Island, British Columbia, Canada10.7589/0090-3558-42.1.175 ↗
40. Multispecies outbreak of cryptococcosis on southern Vancouver Island, British Columbia
41. A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada)10.1073/pnas.0402981101 ↗
42. Byrnes, E.J., Li, W., Lewit, Y., Perfect, J.R., Carter, D.A., Cox, G.M., and Heitman, J. (2009). First reported case of Cryptococcus gattii in the Southeastern USA: Implications for travel-associated acquisition of an emerging pathogen. PLoS ONE, 4.10.1371/journal.pone.0005851 ↗
43. Cryptococcus gattii Complex Infections in HIV-Infected Patients, Southeastern United States10.3201/eid2411.180787 ↗
44. Cryptococcus gattii in the United States: Clinical aspects of infection with an emerging pathogen10.1093/cid/cir723 ↗
45. Spread of Cryptococcus gattii into Pacific Northwest region of the United States10.3201/eid1508.081384 ↗
46. Souto, A.C., Bonfietti, L.X., Ferreira-Paim, K., Trilles, L., Martins, M., Ribeiro-Alves, M., Pham, C.D., Martins, L., Dos Santos, W., and Chang, M. (2016). Population Genetic Analysis Reveals a High Genetic Diversity in the Brazilian Cryptococcus gattii VGII Population and Shifts the Global Origin from the Amazon Rainforest to the Semi-arid Desert in the Northeast of Brazil. PLoS Negl. Trop. Dis., 10.10.1371/journal.pntd.0004885 ↗
47. The Frozen Brain State of Cryptococcus gattii: A Globe-Trotting, Tropical, Neurotropic Fungus10.1007/s12028-018-0538-4 ↗
48. Cryptococcus: From environmental saprophyte to global pathogen10.1038/nrmicro.2015.6 ↗
49. Continental Drift and Speciation of the Cryptococcus neoformans and Cryptococcus gattii Species Complexes10.1128/mSphere.00103-17 ↗
50. Genome Evolution and Innovation across the Four Major Lineages of Cryptococcus gattii10.1128/mBio.00868-15 ↗
51. Cryptococcus gattii in the Age of Whole-Genome Sequencing10.1128/mBio.01761-15 ↗
52. Litvintseva, A.P., and Mitchell, T.G. (2012). Population genetic analyses reveal the African origin and strain variation of Cryptococcus neoformans var. grubii. PLoS Pathog., 8.10.1371/journal.ppat.1002495 ↗
53. What makes Cryptococcus neoformans a pathogen?10.3201/eid0401.980109 ↗
54. Cryptococcus neoformans: Historical curiosity to modern pathogen10.1002/yea.2997 ↗
55. Calcineurin is required for virulence of Cryptococcus neoformans10.1093/emboj/16.10.2576 ↗
56. Characterization of Cryptococcus neoformans variety gattii SOD2 reveals distinct roles of the two superoxide dismutases in fungal biology and virulence10.1111/j.1365-2958.2005.04503.x ↗
57. The trehalose synthesis pathway is an integral part of the virulence composite for Cryptococcus gattii10.1128/IAI.00565-09 ↗
58. Susceptibility of melanized and nonmelanized Cryptococcus neoformans to nitrogen- and oxygen-derived oxidants10.1128/iai.62.7.3004-3007.1994 ↗
59. Role of nitric oxide and melanogenesis in the accomplishment of anticryptococcal activity by the BV-2 microglial cell line10.1016/0165-5728(95)00016-U ↗
60. Melanin as a potential cryptococcal defence against microbicidal proteins10.1046/j.1365-280X.1999.00218.x ↗
61. Effects of melanin upon susceptibility of Cryptococcus to antifungals10.1111/j.1348-0421.2003.tb03395.x ↗
62. Melanization of Cryptococcus neoformans and Histoplasma capsulatum reduces their susceptibilities to amphotericin B and caspofungin10.1128/AAC.46.11.3394-3400.2002 ↗
63. Khajo, A., Bryan, R.A., Friedman, M., Burger, R.M., Levitsky, Y., Casadevall, A., Magliozzo, R.S., and Dadachova, E. (2011). Protection of melanized Cryptococcus neoformans from lethal dose gamma irradiation involves changes in melanin’s chemical structure and paramagnetism. PLoS ONE, 6.10.1371/journal.pone.0025092 ↗
64. The radioprotective properties of fungal melanin are a function of its chemical composition, stable radical presence and spatial arrangement10.1111/j.1755-148X.2007.00430.x ↗
65. Role of laccase in the biology and virulence of Cryptococcus neoformans10.1016/j.femsyr.2004.04.004 ↗
66. Cell wall targeting of laccase of Cryptococcus neoformans during infection of mice10.1128/IAI.01351-06 ↗
67. Melanin deposition in two Cryptococcus species depends on cell-wall composition and flexibility10.1074/jbc.RA119.011949 ↗
68. Chitosan, the deacetylated form of chitin, is necessary for cell wall integrity in Cryptococcus neoformans10.1128/EC.00399-06 ↗
69. Chitosan Biosynthesis and Virulence in the Human Fungal Pathogen Cryptococcus gattii10.1128/mSphere.00644-19 ↗
70. Oxidative killing of Cryptococcus neoformans by human neutrophils. Evidence that fungal mannitol protects by scavenging reactive oxygen intermediates10.4049/jimmunol.156.10.3836 ↗
71. Production of the hexitol D-mannitol by Cryptococcus neoformans in vitro and in rabbits with experimental meningitis10.1128/iai.58.6.1664-1670.1990 ↗
72. Extracellular phospholipase activity is a virulence factor for Cryptococcus neoformans10.1046/j.1365-2958.2001.02236.x ↗
73. Phospholipase C of Cryptococcus neoformans regulates homeostasis and virulence by providing inositol trisphosphate as a substrate for Arg1 kinase10.1128/IAI.01421-12 ↗
74. Phospholipase activity in Cryptococcus neoformans: A new virulence factor?10.1093/infdis/175.2.414 ↗
75. Cryptococcus neoformans phospholipase B1 activates host cell Rac1 for traversal across the blood-brain barrier10.1111/j.1462-5822.2012.01819.x ↗
76. A yeast under cover: The capsule of Cryptococcus neoformans10.1128/EC.2.4.655-663.2003 ↗
77. How sweet it is! Cell wall biogenesis and polysaccharide capsule formation in Cryptococcus neoformans10.1146/annurev.micro.62.081307.162753 ↗
78. Chrissian, C., Lin, C.P., Camacho, E., Casadevall, A., Neiman, A.M., and Stark, R.E. (2020). Unconventional Constituents and Shared Molecular Architecture of the Melanized Cell Wall of C. neoformans and Spore Wall of S. cerevisiae. J. Fungi, 6.10.3390/jof6040329 ↗
79. Hernandez-Chavez, M.J., Perez-Garcia, L.A., Nino-Vega, G.A., and Mora-Montes, H.M. (2017). Fungal Strategies to Evade the Host Immune Recognition. J. Fungi, 3.10.3390/jof3040051 ↗
80. Dynamic Fungal Cell Wall Architecture in Stress Adaptation and Immune Evasion10.1016/j.tim.2018.01.007 ↗
81. Pbx proteins in Cryptococcus neoformans cell wall remodeling and capsule assembly10.1128/EC.00290-13 ↗
82. The Viscoelastic Properties of the Fungal Cell Wall Allow Traffic of AmBisome as Intact Liposome Vesicles10.1128/mBio.02383-17 ↗
83. Cryptococcus neoformans Rim101 is associated with cell wall remodeling and evasion of the host immune responses10.1128/mBio.00522-12 ↗
84. Esher, S.K., Ost, K.S., Kohlbrenner, M.A., Pianalto, K.M., Telzrow, C.L., Campuzano, A., Nichols, C.B., Munro, C., Wormley, F.L., and Alspaugh, J.A. (2018). Defects in intracellular trafficking of fungal cell wall synthases lead to aberrant host immune recognition. PLoS Pathog., 14.10.1371/journal.ppat.1007126 ↗
85. Cell-wall glucans of Cryptococcus neoformans Cap 6710.1016/0008-6215(90)84273-W ↗
86. A chitin synthase and its regulator protein are critical for chitosan production and growth of the fungal pathogen Cryptococcus neoformans10.1128/EC.4.11.1902-1912.2005 ↗
87. Loss of cell wall alpha(1-3) glucan affects Cryptococcus neoformans from ultrastructure to virulence10.1111/j.1365-2958.2006.05551.x ↗
88. Unraveling synthesis of the cryptococcal cell wall and capsule10.1093/glycob/cwy030 ↗
89. The Fungal Cell Wall: Candida, Cryptococcus, and Aspergillus Species
90. Crh1p and Crh2p are required for the cross-linking of chitin to beta(1-6)glucan in the Saccharomyces cerevisiae cell wall10.1111/j.1365-2958.2006.05565.x ↗
91. Glycosyl phosphatidylinositol-dependent cross-linking of alpha-agglutinin and beta 1,6-glucan in the Saccharomyces cerevisiae cell wall10.1083/jcb.128.3.333 ↗
92. Ecto-glycanases and metabolic stability of the capsule in Cryptococcus neoformans10.1002/jobm.200610143 ↗
93. Chitin: A “Hidden Figure” in the Fungal Cell Wall
94. Studies on chitosan: 4. Lysozymic hydrolysis of partially N-acetylated chitosans10.1016/S0141-8130(05)80032-7 ↗
95. Chitinases are essential for sexual development but not vegetative growth in Cryptococcus neoformans10.1128/EC.00227-09 ↗
96. Extracellular glycosylphosphatidylinositol-anchored mannoproteins and proteases of Cryptococcus neoformans10.1111/j.1567-1364.2006.00198.x ↗
97. Comprehensive proteomic analysis of Saccharomyces cerevisiae cell walls: Identification of proteins covalently attached via glycosylphosphatidylinositol remnants or mild alkali-sensitive linkages10.1074/jbc.M500334200 ↗
98. The contribution of Pir protein family to yeast cell surface display10.1007/s00253-014-5538-5 ↗
99. Estimating the relative contributions of virulence factors for pathogenic microbes10.1128/IAI.74.3.1500-1504.2006 ↗
100. Immunomodulatory Role of Capsular Polysaccharides Constituents of Cryptococcus neoformans10.3389/fmed.2019.00129 ↗